Welcome to the e-CCO Library!

P228: Prevalence and risk factor of CMV infection among hospitalized patients with ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Song G.A., Baek D.H., Han I.S., Han S.Y.

Created: Wednesday, 20 February 2019, 10:36 AM
P228: Prevalence of malnutrition and nutritional characteristics of patients with inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Casanova*1, M. Chaparro1, B. Molina2, O. Merino3, O. Nuevo-Siguairo4, C. Dueñas-Sadornil5, A.M. García-Albert6, D. Hervías7, X. Calvet8, L. Bujanda9, G.E. Rodríguez10, M. Montoro11, L. Castro-Laria12, M. Barreiro-de Acosta13, M. Van Domselaar14, J. M. Huguet15, P. Ramírez de la Piscina16, J. Barrio17, A. Algaba18, A. D. Ávila19, S. Torra20, L. Pozzati21, F. J. Martínez-Cerezo22, M. Calvo23, M. Charro24, P. López-Serrano25, M. R. Arribas-López26, M. Muñoz Vicente27, M. L. Rincón28, A. C. Peláez29, E. Castro30, A. García-Herola31, R. Batanero32, A. Castaño-García33, P. Robledo-Andrés34, M. B. Gómez-Sánchez35, A. Figuerola36, J. M. Banales37, L. Díaz-Hernández10, I. Vázquez38, F. Arguelles-Arias12, E. Marti-Bonmati39, F. Bermejo18, P. Serrano40, I. Megias-Rangil41, M. Campderá42, A. Barragán43, A. Merchante44, J. P. Gisbert1

Created: Friday, 22 February 2019, 9:49 AM
P228: Ultrasound for assessing disease activity in ulcerative colitis: Development of a novel ultrasonographic disease activity index
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Bots1*, K. Nylund2, M. Löwenberg1, K. Gecse1, O.H. Gilja2, G. D'Haens1

Created: Thursday, 21 February 2019, 9:14 AM
P229 PillCamCrohn’sCapsule: the use of a panenteric capsule endoscopy in a Portuguese centre
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Gomes, M. Sousa, A. Ponte, R. Pinho, A. Rodrigues, J.C. Rocha Silva, E. Afecto, J. Carvalho

Created: Thursday, 30 January 2020, 10:12 AM
P229: Capsule endoscopy is useful in the diagnosis and monitoring of postoperative recurrence in Crohn’s disease. Analysis from an 11-year cohort.
Year: 2022
Source: ECCO'22
Authors: Elosua Gonzalez, A.(1);Rullan, M.(1);Rubio, S.(2);Elizalde, I.(2);Rodríguez, C.(2);Aznárez, M.R.(2);Vicuña, M.(2);Juanmartiñena, J.F.(2);Fernández-Urién, I.(2);Nantes, Ó.(2);
Created: Friday, 11 February 2022, 3:52 PM
P229: Comparison of the characteristics of segmental mucosal microbiome according to the extent of inflammation in ulcerative colitis.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Shin, J.(1)*;Kim, S.Y.(1);Kwon, D.(1);Cha, B.(1);Kong, S.M.(2);Kim, J.S.(3);Kwon, K.S.(1);Kim, H.(1);
Created: Friday, 14 July 2023, 10:48 AM
P229: Evidence of content validity and psychometric properties of SF-36 for measuring health-related quality of life of patients with Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Yarlas1, M. White1, M. Ingham2, D. Naessens*3, C. Han3

Created: Friday, 22 February 2019, 9:49 AM
P229: Standardization of Quantum Blue® rapid TDM assays with WHO international standards for adalimumab and infliximab
Year: 2021
Source: ECCO'21 Virtual
Authors: Afonso, J.(1);Ricken, B.(1);Schuster, T.(1);Guschin, D.(1);Schneider, M.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P229: The modified postoperative endoscopic recurrence score for Crohn's disease: Does it really make a difference in predicting clinical recurrence?
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Rivière P.*1, Vermeire S.2, Van Assche G.2, Rutgeerts P.2, De Buck van Overstraeten A.3, D'Hoore A.3, Ferrante M.2

Created: Wednesday, 20 February 2019, 10:36 AM
P229: The new biosimilar of infliximab SB2 can be quantified by IFX-optimised therapeutic drug monitoring assays
Year: 2018
Source: ECCO '18 Vienna
Authors:

F. Magro1,2,3, C. Rocha4,5, A.I. Vieira6, H. T. Sousa7, I. Rosa8, S. Lopes9, J. Carvalho10, C.C. Dias11,12, J. Afonso1,3*

Created: Thursday, 21 February 2019, 9:14 AM
P229: The relationship between computed tomography enterography findings and levels of faecal biomarkers in patients with small bowel Crohn’s disease: A prospective study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Shimoyama*1, T. Yamamoto1, S. Umegae1, K. Matsumoto1

Created: Friday, 22 February 2019, 9:41 AM
P230 Health-related quality of life in adolescents and young adults (AYA) with inflammatory bowel disease and its correlations with demographic, clinical, laboratory and therapeutic evaluations
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Oba1, M. Deboni1, R. Toma1, C. Sobrado2, M. Azevedo3, A. Carlos3, M. Borba2, A. Damião3, F. Carrilho3, C. Silva4

Created: Thursday, 30 January 2020, 10:12 AM
P230: A first pregnancy seems associated with a positive effect on the course of inflammatory bowel disease: Data from a prospective pregnancy cohort
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. van der Giessen*, S. Kanis, G. Fuhler, C. van der Woude

Created: Thursday, 21 February 2019, 9:14 AM
P230: Adalimumab in Crohn's disease is protective against periodontitis based on a validated oral health questionnaire
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Saravanapavan, H.(1,2)*;Rath, S.(1,2);Inniss, S.(1,2);Ong, M.(1);Sabalić, M.(3);D'Aiuto, F.(3);Rahman, F.(1,2);Smith, A.M.(1);
Created: Friday, 14 July 2023, 10:48 AM
P230: Development of a Japanese version of the IBD Self-Efficacy Scale and evaluation of its current status in Japan
Year: 2021
Source: ECCO'21 Virtual
Authors: Tanaka, M.(1);Kawakami, A.(1);Sakagami, K.(2);Terai, T.(3);Ito, H.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P230: Elevated angiopoietins independent of TNF α regulation appear to play a key role in immune mediated angiogenesis in inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Hussey*1, G. Holleran1, K. Grooteman2, S. Smith3, D. McNamara1

Created: Friday, 22 February 2019, 9:49 AM
P230: Methotrexate in the treatment of Crohn's disease: a Portuguese real-life single center experience
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Peixoto A., Silva M., Morais R., Liberal R., Lopes S., Magro F., Macedo G.

Created: Wednesday, 20 February 2019, 10:36 AM
P230: Prediction of loss of response to anti-TNF therapy using SES-CD in patients with Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

Y. Fuyuno*1, T. Torisu1, A. Hirano1, S. Fujioka1,2, J. Umeno1, T. Moriyama1,3, T. Kitazono1, M. Esaki4

Created: Friday, 22 February 2019, 9:41 AM
P230: Ultrasonography-based and Magnetic Resonance-based Lémann Index: two sides of the same coin
Year: 2022
Source: ECCO'22
Authors: Allocca , M.(1);Dell'Avalle , C.(2);Radice , S.(1);Bonifacio , C.(3);Furfaro , F.(4);Zilli , A.(1);D'Amico , F.(1);Peyrin-Biroulet , L.(5);Danese , S.(1);Fiorino , G.(1);
Created: Friday, 11 February 2022, 3:52 PM
P231 Epidemiological profile and long-term outcomes from a large PSC-IBD cohort
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A.E. Caon, C. Martins, M. Cruz, L. Leite Barros, M. Azevedo, N. Queiroz, A. Carlos, L. Milane, J. Oba, M. Braga, A. Sipahi, A. Damião, E. Cançado

Created: Thursday, 30 January 2020, 10:12 AM